Andreas Brandt has been working as a statistical assessor in the Biostatistics and Special Pharmacokinetics unit at BfArM (Federal Institute for Drugs and Medical Devices) since 2010. He is an expert of the Biostatistics Working Party (BSWP) at the European Medicines Agency (EMA). Before joining the BfArM, he was a PhD student and post-doctoral scientist at the German Cancer Research Center (DKFZ), Heidelberg, from 2007 to 2010. He holds a diploma in Mathematics (MSc equivalent) and a PhD in Genetic Epidemiology.

Ina Rondak is working for the EMA as a Statistician in the Methodology workstream of the Data Analytics and Methods Task Force since 2020 and was seconded to the EMA as National Expert since 2015. Prior to that she worked at the Institute of Medical Statistics and Epidemiology of the university hospital of TU München and holds a degree in Statistics from LMU München and a Postgraduate Diploma in Medical Statistics from the University of Auckland. She was coordinating the development of the methodological guidance in relation to the COVID-19 pandemic and the war in Ukraine.